Weiss Multi-Strategy Advisers’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,517
Closed -$312K 196
2023
Q4
$312K Sell
11,517
-43,483
-79% -$1.14M 0.01% 491
2023
Q3
$1.63M Sell
55,000
-20,770
-27% -$730K 0.04% 395
2023
Q2
$2.71M Sell
75,770
-73,615
-49% -$2.11M 0.05% 418
2023
Q1
$3.5M Buy
149,385
+137,885
+1,199% +$3.94M 0.08% 328
2022
Q4
$313K Buy
+11,500
New +$526K 0.01% 532
2021
Q1
Sell
-2,500
Closed -$322K 748
2020
Q4
$322K Buy
2,500
+500
+25% +$57.5K 0.01% 617
2020
Q3
$224K Sell
2,000
-5,014
-71% -$459K 0.01% 526
2020
Q2
$569K Buy
+7,014
New +$565K 0.02% 461

Other funds holding GH

Weiss Multi-Strategy Advisers's GH Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Guardant Health (GH) in Q1 2024, closing a stake of 11,517 shares — an estimated $312K sold.

Weiss Multi-Strategy Advisers first reported a position in GH in Q2 2020 and held it in 8 quarters. The position peaked at $3.5M in Q1 2023. 257 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 11,517 Guardant Health shares in Q1 2024, an estimated $312K.
  • Weiss Multi-Strategy Advisers first reported a position in Guardant Health in Q2 2020 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Guardant Health position peaked at $3.5M in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.